Improving the targeting of therapeutics with single-domain antibodies
- 8 January 2016
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Delivery
- Vol. 13 (4) , 561-570
Abstract
Introduction: The targeted delivery of therapeutic agents greatly increases their effectiveness while simultaneously reducing negative side effects. In the past, targeting of therapeutics has been ...Keywords
Funding Information
- Defense Threat Reduction Agency (MIPR# B112582M)
This publication has 64 references indexed in Scilit:
- Targeted Radionuclide Therapy - An OverviewCurrent Radiopharmaceuticals, 2013
- Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranosticsProceedings of the National Academy of Sciences, 2013
- A prodrug nanoassembly entrapping drugs as a tumor-targeted delivery systemChemical Communications, 2013
- Acid-Active Cell-Penetrating Peptides for in Vivo Tumor-Targeted Drug DeliveryJournal of the American Chemical Society, 2012
- The Future of Peptide‐based DrugsChemical Biology & Drug Design, 2012
- Therapeutic Applications of Nucleic Acids and Their Analogues in Toll-like Receptor SignalingMolecules, 2012
- DNA aptamer functionalized nanomaterials for intracellular analysis, cancer cell imaging and drug deliveryCurrent Opinion in Chemical Biology, 2012
- Near‐Infrared Light‐Triggered, Targeted Drug Delivery to Cancer Cells by Aptamer Gated NanovehiclesAdvanced Materials, 2012
- The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapyChemical Society Reviews, 2012
- Introduction to current and future protein therapeutics: A protein engineering perspectiveExperimental Cell Research, 2011